Molecular Medicine Flashcards
molecular medicine
definition
application of molecular bio + biochem + genetics to diagnosis and treatment of disease
common cause of breast/ovarian cancer
BRCA1/2 mutations
breast lifetime risk w/mutation= 45-85%
ovarian lifetime risk w/mutation= 39-46% (1) or 10-27% (2)
PCR
amplify DNA by sep template strands then bind oligonucleotides (primers) for polymerase to extend/amplify b/t primers
shows known polymorphisms in selected regions, single genes/locus
olig can be allele specific
whole genome sequence
shows all SNPs, all mutations
more affordable and widely used, but remember 99% genome not expressed
exome
aka exon portion, the 1% of the genome that is actually expressed
whole exome sequencing
allele specific arrays
oligonucleotides bind just to WT or mutant sequence then fragment and label DNA
detect label by hybridization to mutant ASO indicates presence of mutation
DNA sequencing
determine nucleotide sequencing
- di-deoxy chain termination method - classic but only 1000 bp/reaction
- next generation sequencing - miniaturization of reactions, larger sequence length but challenging to reconstruct
SNP typing
only bits of genome that are known to vary
DNA methylation sequencing
bisulfite sequencing (coverts C to U) then PCR converts (U to T)
C bases that were converted to T were NOT methylated in og sample
tissue specific
FISH
hybridize labelled DNA probe to genomic DNA in interphase nucleus
-should be 2 fluorescent sites for autosomal loci
-3 loci = region is present in 3 copies (trisomy)
-1 loci = one copy (monosomy)
cancer-MGPT
MGPT (multigene panel testing) to determine seq of known oncogenes and tumor suppressors
classifications: pathogenic, likely patho, uncertain significance, likely benign, benign
can predict risk/prognosis/suggest treatment
prenatal diagnosis techniques
- chromosome analysis i.e karyotype/FISH (detects numerical and structural aberrations)
- exome sequencing (when karyotype is normal, single gene disorders)
- cell free fetal (maternal)
turnaround time critical for reprod decisions and intrauterine intervention
pharmacogenomics
develop an indiv drug treatment plan but response hard to predict with accuracy
i.e Warfarin (oral anticoagulant)
Warfarin
inhibits vitamin K epoxide reductase (VKORC1) so polymorphism affects sensitivity
metabolized by P450 enzyme (CYP2C9) so polymorphism affects sensitivity
considerations before testing
- what to do with info aka will it help prevent disease or worry pt
- who will have access- HIPAA, GINA (genetic discrim protection in employment and health insurance)
- incidental findings
- ethics
qRT-PCR
for RNA analysis, normal PCR not work
-reverse transcriptase (RNA > cDNA)
shows amount of a few select RNA molecules in sample